Compound: 141318-62-9
SMILES: O=C(c1c2c3c([nH]cc3C[C@@H](C2)N(CCC)CCC)cc1)C
InChIKey: CKYZLYQSDNLGPT-HNNXBMFYSA-N
Synonyms: 141318-62-9, LY 293284, LY-293284, 92MME29XHM, Ethanone, 1-(4-(dipropylamino)-1,3,4,5-tetrahydrobenz(cd)indol-6-yl)-, (R)-, DTXSID70161692, 1-[(4R)-4-(Dipropylamino)-1,3,4,5-tetrahydrobenz[cd]indol-6-yl]ethanone, 1-((4R)-4-(Dipropylamino)-1,3,4,5-tetrahydrobenz(cd)indol-6-yl)ethanone, RefChem:907120, DTXCID6084183, LY293284, 6-Acetyl-4-(di-n-propylamino)-1,3,4,5-tetrahydrobenz(c,d)indole, 1-[(4R)-4-(dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indol-6-yl]ethanone, Ethanone, 1-[(4R)-4-(dipropylamino)-1,3,4,5-tetrahydrobenz[cd]indol-6-yl]-, 1-(4-Dipropylamino-1,3,4,5-tetrahydro-benzo[cd]indol-6-yl)-ethanone, LY-293,284, GTPL19, UNII-92MME29XHM, orb1700067, SCHEMBL6902000, AKOS040748818, DA-55091, HY-120396, CS-0077867, Q6460414, 1-[(4R)-4-(Dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indol-6-yl]ethan-1-one, 1-[(6R)-6-(dipropylamino)-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),3,8(12),9-tetraen-9-yl]ethan-1-one
Theoretical properties:
molecular_formula: C19H26N2O
molecular_weight: 298.4 g/mol
exact_mass: 298.204513457 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 6
heavy_atom_count: 22
topological_polar_surface_area: 36.1 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
{"pubchem": null, "chebi": null, "chembl": null, "wikipedia": "Partial or simplified ergolines and lysergamides are analogues of ergolines and lysergamides like the psychedelic drug LSD in which one or more atoms or bonds, for instance within the ergoline ring system, have been removed. Additional substitutions may also be added, for instance on the A ring of the ergoline nucleus. It is notable that the ergoline ring system contains embedded tryptamine and phenethylamine moieties within its structure, and so some partial ergolines are simple tryptamines, cyclized tryptamines, simple phenethylamines, and/or cyclized phenethylamines.\nIn terms of pharmacology, partial lysergamides include serotonin and dopamine receptor agonists. Some, like NDTDI (9-nor-LSD), DEMPDHPCA (dides-B,C-LSD), DEIMDHPCA (4-nor-LSD), and LPH-5 ((S)-2C-TFM-3PIP), are serotonin 5-HT2A receptor agonists and have psychedelic-like and/or psychoplastogenic effects. Some, like 8-OH-DPAT, LY-178210 (LY-228729; 4,\u03b1-methylene-5-carboxamido-DPT), Bay R 1531 (LY-197206; 4,\u03b1-methylene-5-MeO-DPT), and LY-293284 (4,\u03b1-methylene-5-acetyl-DPT), are selective serotonin 5-HT1A receptor agonists. Others, like ropinirole, rotigotine, nolomirole, and RU-28251 (4,\u03b1-methylene-DPT), are dopamine D2-like receptor agonists. Though limitedly studied, partial ergolines have generally shown markedly reduced potency in terms of hallucinogen-like effects compared to LSD.\nExamples of partial lysergamides that are simple tryptamines include N-DEAOP-NMT (9,10-dinor-LSD) and 5-MeO-N-DEAOP-NMT and examples that are simple phenethylamines include N-DEAOP-NMPEA and 25D-NM-NDEAOP. An example of a cyclized tryptamine-like compound is DEIMDHPCA, while examples of cyclized phenethylamines include DEMPDHPCA, DEMPDHPCA-2C-D, and LPH-5. Some, like 8-OH-DPAT and rotigotine, are 2-aminotetralins. Others, like NDTDI and LY-178210, are tricyclic compounds that contain both tryptamine and phenethylamine components. Tochergamine is a simplified analogue of ergometrine that was studied as an oxytocic agent but was abandoned."}